Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374,002,024
-
Total 13F shares
-
231,045,000
-
Share change
-
+8,060,341
-
Total reported value
-
$4,816,727,618
-
Put/Call ratio
-
111%
-
Price per share
-
$20.80
-
Number of holders
-
315
-
Value change
-
+$197,335,196
-
Number of buys
-
135
-
Number of sells
-
152
Institutional Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q4 2020
As of 31 Dec 2020,
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) was held by
315 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
231,045,000 shares.
The largest 10 holders included
PAULSON & CO. INC., ValueAct Holdings, L.P., GLENVIEW CAPITAL MANAGEMENT, LLC, GOLDENTREE ASSET MANAGEMENT LP, VANGUARD GROUP INC, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, Permian Investment Partners, LP, ROYAL BANK OF CANADA, and Kohlberg Kravis Roberts & Co. L.P..
This page lists
315
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.